Jean Jacques Bienaime, Director at Immunome Inc. (IMNM), bought 2,000 shares at $13.57 ($27K) on 2024-05-21, disclosed to the SEC on 2024-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |